Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
7.46
+0.26 (3.61%)
At close: Jul 9, 2025, 4:00 PM
7.50
+0.04 (0.54%)
After-hours: Jul 9, 2025, 4:03 PM EDT
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $14.10 million as of July 9, 2025.
Market Cap
14.10M
Enterprise Value
-2.75M
1-Year Change
n/a
Ranking
Category
Stock Price
$7.46
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $14.10M, an increase of 30.69%. That is a compound annual growth rate of 64.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2025 | 13.54M | 142.51% |
| Dec 31, 2024 | 5.58M | -48.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.83B |
| Johnson & Johnson | 373.59B |
| AbbVie | 331.43B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 275.51B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 232.62B |
| AstraZeneca | 216.19B |